Polar Capital’s Thermo Fisher Scientific TMO Stock Holding History

Polar Capital’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$14.7M	Sell	33,188 -50,755	-60%	-$21M	0.11%	159
2020 Q2	$30.4M	Buy	83,943 +60,186	+253%	+$20.2M	0.26%	100
2020 Q1	$6.74M	Sell	23,757 -4,771	-17%	-$1.5M	0.07%	190
2019 Q4	$9.27M	Sell	28,528 -5,692	-17%	-$1.73M	0.08%	204
2019 Q3	$9.97M	Hold	34,220	–	–	0.09%	197
2019 Q2	$10.1M	Sell	34,220 -153,771	-82%	-$42.4M	0.09%	189
2019 Q1	$51.5M	Sell	187,991 -75,000	-29%	-$18.7M	0.48%	69
2018 Q4	$58.9M	Buy	262,991 +229,388	+683%	+$53.8M	0.63%	47
2018 Q3	$8.2M	Sell	33,603 -285,209	-89%	-$65.6M	0.07%	189
2018 Q2	$66K	Buy	318,812 +263,390	+475%	+$55.9M	0.4%	48
2018 Q1	$11.4M	Buy	55,422 +35,603	+180%	+$7.47M	0.12%	175
2017 Q4	$3.76M	Buy	+19,819	New	+$3.8M	0.04%	212
2017 Q2	–	Sell	-167,496	Closed	-$25.7M	–	268
2017 Q1	$25.7M	Sell	167,496 -2,146	-1%	-$328K	0.39%	91
2016 Q4	$23.9M	Sell	169,642 -47,764	-22%	-$7.04M	0.38%	82
2016 Q3	$34.6M	Sell	217,406 -139,615	-39%	-$21.5M	0.6%	43
2016 Q2	$52.8M	Buy	357,021 +121,975	+52%	+$18M	1%	26
2016 Q1	$33.3M	Buy	235,046 +9,462	+4%	+$1.27M	0.63%	47
2015 Q4	$32M	Sell	225,584 -46,584	-17%	-$6.21M	0.58%	54
2015 Q3	$33.3M	Sell	272,168 -345,223	-56%	-$45M	0.67%	43
2015 Q2	$80.1M	Sell	617,391 -27,208	-4%	-$3.55M	1.54%	7
2015 Q1	$86.6M	Buy	644,599 +622,892	+2,870%	+$80.3M	1.64%	7
2014 Q4	$2.72M	Buy	21,707 +7,159	+49%	+$871K	0.05%	199
2014 Q3	$1.77M	Buy	14,548 +2,973	+26%	+$361K	0.04%	213
2014 Q2	$1.37M	Sell	11,575 -246,120	-96%	-$29M	0.03%	235
2014 Q1	$31M	Sell	257,695 -39,330	-13%	-$4.68M	0.71%	34
2013 Q4	$33.1M	Sell	297,025 -77,450	-21%	-$7.7M	0.79%	32
2013 Q3	$34.5K	Buy	374,475 +90,185	+32%	+$8.16M	0.92%	21
2013 Q2	$24.1M	Buy	+284,290	New	+$23.7M	0.84%	27

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Polar Capital's TMO Position: Q3 2020 in Review

Polar Capital reduced its Thermo Fisher Scientific (TMO) stake by 60% in Q3 2020, selling an estimated $21M and leaving 33,188 shares worth $14.7M. The position accounts for 0.11% of the portfolio, ranked #159.

Polar Capital first reported a position in TMO in Q2 2013 and has held it in 28 quarters since. The position peaked at $86.6M in Q1 2015. 1,847 funds tracked by Wall St. Rank hold TMO as of Q3 2020.

Polar Capital held 33,188 shares of Thermo Fisher Scientific worth $14.7M as of Q3 2020.
Polar Capital sold 50,755 Thermo Fisher Scientific shares in Q3 2020, an estimated $21M.
Thermo Fisher Scientific made up 0.11% of Polar Capital's portfolio in Q3 2020, its #159 holding.
Polar Capital first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 28 quarters since.
Polar Capital's Thermo Fisher Scientific position peaked at $86.6M in Q1 2015.
1,847 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2020.

Based on Polar Capital's 13F filing for Q3 2020, filed 16 Nov 2020.